| Certificates/Standards: | Not provided |
| Monthly Output: | Not provided |
| Regional: | North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | Not provided |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
Bi-layer tablets are a subset of Lipa’s core tableting capabilities but it is an unique and exacting innovative dosage format that combines two separate and accurately dosed parts into the one tablet.
This capability offers several distinct advantages over single layer tablets with the ability to:
- Separate actives that are incompatible when mixed in a single dosage unit therefore improving quality and long term stability.
- Formulate with two distinct and different time release profiles in one dosage form thus potentially providing an immediate release and a sustained release tablet portion to ensure an optimized therapeutic benefit from all the actives incorporated in the overall tablet matrix.
This technology has a wide range of potential applications and continues to provide our customers with optimized, active delivery systems as well as aesthetically novel and appealing dosage options.
沪公网安备31010402001403号
